Pure Harvest Corporate Group, Inc. Share Price Other OTC
Equities
PHCG
US74625M1018
Pharmaceuticals
Sales 2019 | 0.04 3.21 | Sales 2020 | 0.74 61.27 | Capitalization | 31.42M 2.62B |
---|---|---|---|---|---|
Net income 2019 | -1M -83.29M | Net income 2020 | -6M -500M | EV / Sales 2019 | 43,08,96,057 x |
Net cash position 2019 | 457K 38.04M | Net Debt 2020 | 2.87M 239M | EV / Sales 2020 | 4,66,05,076 x |
P/E ratio 2019 |
-15.5
x | P/E ratio 2020 |
-3.88
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 62.22% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02/15/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02/15/02 |
1st Jan change | Capi. | |
---|---|---|
+41.06% | 6.19B | |
-15.95% | 4.48B | |
+6.36% | 3.29B | |
-11.34% | 3.12B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.64B | |
-11.32% | 1.56B |